Cargando…

L‐myc Restriction Fragment Length Polymorphism in Japanese Patients with Esophageal Cancer

L‐myc polymorphism is a representative genetic trait related to an individual's susceptibility to several cancers. However, there have been no reports concerning the association between esophageal cancer and L‐myc polymorphism. To analyze the distribution of polymorphism in Japanese patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibuta, Kenji, Inoue, Hiroshi, Sato, Koichi, Matsuyama, Ayumi, Ueo, Hiroaki, Tanaka, Youichi, Mafune, Kenichi, Barnard, Graham F., Mori, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926334/
https://www.ncbi.nlm.nih.gov/pubmed/10761707
http://dx.doi.org/10.1111/j.1349-7006.2000.tb00932.x
_version_ 1783318882076852224
author Shibuta, Kenji
Inoue, Hiroshi
Sato, Koichi
Matsuyama, Ayumi
Ueo, Hiroaki
Tanaka, Youichi
Mafune, Kenichi
Barnard, Graham F.
Mori, Masaki
author_facet Shibuta, Kenji
Inoue, Hiroshi
Sato, Koichi
Matsuyama, Ayumi
Ueo, Hiroaki
Tanaka, Youichi
Mafune, Kenichi
Barnard, Graham F.
Mori, Masaki
author_sort Shibuta, Kenji
collection PubMed
description L‐myc polymorphism is a representative genetic trait related to an individual's susceptibility to several cancers. However, there have been no reports concerning the association between esophageal cancer and L‐myc polymorphism. To analyze the distribution of polymorphism in Japanese patients with esophageal cancer, a molecular genotyping method using a polymerase chain reaction‐based restriction fragment length polymorphism (PCR‐RFLP) was used. Based on an analysis of 65 Japanese patients with esophageal cancer and 107 healthy control subjects, a significant difference was observed in either the distribution of genotypes (P=0.012) or of allele frequencies between the two groups (P 0.004). The relative risk of esophageal cancer for genotypes including the shorter allele was 2.9 compared to the longer allele homozygote. Furthermore, the patients with S‐allele had a tendency for poor prognosis among those with three genotypes. A significant difference between the distribution of genotypes and the incidence of lymph node metastasis was found based on the clinicopathological features of the cancers. These results suggest that L‐myc polymorphism may be implicated as a genetic trait affecting an individual's susceptibility to esophageal cancer, at least among Japanese patients.
format Online
Article
Text
id pubmed-5926334
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-59263342018-05-11 L‐myc Restriction Fragment Length Polymorphism in Japanese Patients with Esophageal Cancer Shibuta, Kenji Inoue, Hiroshi Sato, Koichi Matsuyama, Ayumi Ueo, Hiroaki Tanaka, Youichi Mafune, Kenichi Barnard, Graham F. Mori, Masaki Jpn J Cancer Res Article L‐myc polymorphism is a representative genetic trait related to an individual's susceptibility to several cancers. However, there have been no reports concerning the association between esophageal cancer and L‐myc polymorphism. To analyze the distribution of polymorphism in Japanese patients with esophageal cancer, a molecular genotyping method using a polymerase chain reaction‐based restriction fragment length polymorphism (PCR‐RFLP) was used. Based on an analysis of 65 Japanese patients with esophageal cancer and 107 healthy control subjects, a significant difference was observed in either the distribution of genotypes (P=0.012) or of allele frequencies between the two groups (P 0.004). The relative risk of esophageal cancer for genotypes including the shorter allele was 2.9 compared to the longer allele homozygote. Furthermore, the patients with S‐allele had a tendency for poor prognosis among those with three genotypes. A significant difference between the distribution of genotypes and the incidence of lymph node metastasis was found based on the clinicopathological features of the cancers. These results suggest that L‐myc polymorphism may be implicated as a genetic trait affecting an individual's susceptibility to esophageal cancer, at least among Japanese patients. Blackwell Publishing Ltd 2000-02 /pmc/articles/PMC5926334/ /pubmed/10761707 http://dx.doi.org/10.1111/j.1349-7006.2000.tb00932.x Text en
spellingShingle Article
Shibuta, Kenji
Inoue, Hiroshi
Sato, Koichi
Matsuyama, Ayumi
Ueo, Hiroaki
Tanaka, Youichi
Mafune, Kenichi
Barnard, Graham F.
Mori, Masaki
L‐myc Restriction Fragment Length Polymorphism in Japanese Patients with Esophageal Cancer
title L‐myc Restriction Fragment Length Polymorphism in Japanese Patients with Esophageal Cancer
title_full L‐myc Restriction Fragment Length Polymorphism in Japanese Patients with Esophageal Cancer
title_fullStr L‐myc Restriction Fragment Length Polymorphism in Japanese Patients with Esophageal Cancer
title_full_unstemmed L‐myc Restriction Fragment Length Polymorphism in Japanese Patients with Esophageal Cancer
title_short L‐myc Restriction Fragment Length Polymorphism in Japanese Patients with Esophageal Cancer
title_sort l‐myc restriction fragment length polymorphism in japanese patients with esophageal cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926334/
https://www.ncbi.nlm.nih.gov/pubmed/10761707
http://dx.doi.org/10.1111/j.1349-7006.2000.tb00932.x
work_keys_str_mv AT shibutakenji lmycrestrictionfragmentlengthpolymorphisminjapanesepatientswithesophagealcancer
AT inouehiroshi lmycrestrictionfragmentlengthpolymorphisminjapanesepatientswithesophagealcancer
AT satokoichi lmycrestrictionfragmentlengthpolymorphisminjapanesepatientswithesophagealcancer
AT matsuyamaayumi lmycrestrictionfragmentlengthpolymorphisminjapanesepatientswithesophagealcancer
AT ueohiroaki lmycrestrictionfragmentlengthpolymorphisminjapanesepatientswithesophagealcancer
AT tanakayouichi lmycrestrictionfragmentlengthpolymorphisminjapanesepatientswithesophagealcancer
AT mafunekenichi lmycrestrictionfragmentlengthpolymorphisminjapanesepatientswithesophagealcancer
AT barnardgrahamf lmycrestrictionfragmentlengthpolymorphisminjapanesepatientswithesophagealcancer
AT morimasaki lmycrestrictionfragmentlengthpolymorphisminjapanesepatientswithesophagealcancer